Trisalus Life Sciences

Detailed price information for Trisalus Life Sciences Inc (TLSI-Q) from The Globe and Mail including charting and trades.

Mr. Stansky was a Managing Director of Tudor Investment Corporation where he was responsible for long/short equity, crossover, and venture capital investments. He helped establish Tudor's equity investment group in 1994 and retired from active investment

David Patience was appointed Chief Financial Officer beginning in July 2025. David has nearly 20 years of experience as a financial executive across healthcare and financial services. Prior to TriSalus, David served as Chief Financial Officer at Accelerat

Dr Richard Marshall was appointed as Medical Director in January 2025. Dr. Marshall is an Interventional Radiologist who continues to have an active outpatient and inpatient practice. After graduating from Tulane University School of Medicine, he complete

An accomplished pharmaceutical executive and strategic business leader, Dr. Gordon has extensive experience in the development of drugs from first in-human studies to approval and commercialization. Dr. Gordon brings innovative approaches to the process,

William "Bill" Valle is the Executive Chairman of Compassus, a leading provider of hospice, home health, palliative, and infusion services, and serves on the board of directors of American Oncology Network, a community-based oncology company. He has held